Nicholas Thatcher

The Christie Hospital — United Kingdom

Medicine · Health Sciences

42h-index6.9kcitations189works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(77), Lung Cancer Research Studies(68), Neuroendocrine Tumor Research Advances(29), Lung Cancer Diagnosis and Treatment(28), Cancer therapeutics and mechanisms(26)

Publications189 total

Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non–small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study
Clinical Cancer Research·2019· 2 citedOpen Access
A study of temperature control in different designs of emergency drug transport bags
Anaesthesia·2019· 2 citedOpen Access
Biosimilars: What the Oncologist should Know
Future Oncology·2019· 28 citedOpen Access
Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non–small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study
Clinical Cancer Research·2019· 65 cited
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer
Annals of Oncology·2018· 38 citedOpen Access
The Effect of Necitumumab in Combination with Gemcitabine-Cisplatin on Health-Related Quality of Life (HRQOL) and Tolerability: Squire Trial Patients with Epidermal Growth Factor Receptor (EGFR)-Expressing Squamous NSCLC Tumours
Value in Health·2016· 1 cited
Hypomagnesaemia and its management following treatment with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs): Results from 3 randomized studies of necitumumab (NECI) plus chemotherapy in first-line treatment of patients with stage IV non-small cell lung cancer (NSCLC)
Annals of Oncology·2016Open Access
Radiological Outcomes and Operative Time following Total Knee Arthroplasty using Accelerometer-based, Portable Navigation versus Conventional Inter-Medullary Alignment Guides
Orthopaedic Journal of Sports Medicine·2016· 1 citedOpen Access
Supplementary Material for: Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)
Figshare·2016Open Access
Response to ‘How we define hyponatremia?’
European Journal of Clinical Investigation·2015
Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK
Drugs·2015· 144 citedOpen Access
‘Dos and don’ts’ in the management of hyponatremia
Current Medical Research and Opinion·2015· 34 cited
The diagnosis and management of inpatient hyponatraemia and SIADH
European Journal of Clinical Investigation·2015· 87 citedOpen Access
Quality-Of-Life (Qol), Tolerability, and Supportive Care Results: Necitumumab Phase 3 Squire Study
Annals of Oncology·2014· 1 citedOpen Access
Therapeutic vaccines for cancer: an overview of clinical trials
Nature Reviews Clinical Oncology·2014· 751 cited
Awareness and understanding of cancer immunotherapy in Europe
Human Vaccines & Immunotherapeutics·2014· 9 citedOpen Access
Age as a prognostic factor in small cell lung cancer: a pooled analysis of randomized clinical trials from the Manchester lung cancer group (MLCG) and theUK medical research council clinical trials unit (MRC CTU)
Research Explorer (The University of Manchester)·2013
Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)
Annals of Oncology·2013· 55 cited
Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial
Journal of Clinical Oncology·2012· 185 cited
Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer
Annals of Oncology·2011· 29 cited
page 1 of 10Next →

Frequent Co-authors

Michael Lind(6), Penelope Hopwood(5), Geoffrey P. Margison(5), Heather Anderson(5), Siow Ming Lee(5), Paul Lorigan(4), Derek Crowther(4), R. Stout(4), Mark R. Middleton(4), D.J. Girling(3), Richard Stephens(3), P.A. Burt(3), Dorothy J. Donnelly(3), R. Stanley McElhinney(3), T. Brian H. McMurry(3), Linda Ashcroft(3), Tudor–Eliade Ciuleanu(2), J.H. Scarffe(2), D. Crowther(2), TM Dexter(2)